Class information for:
Level 1: OSTEOBLASTIC METASTASIS//3 D COLLAGEN//AHTO 7

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
31616 120 36.3 69%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
157 21931 BENIGN PROSTATIC HYPERPLASIA//PROSTATE CANCER//PROSTATE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 OSTEOBLASTIC METASTASIS Author keyword 4 36% 7% 8
2 3 D COLLAGEN Author keyword 1 50% 1% 1
3 AHTO 7 Author keyword 1 50% 1% 1
4 ANTI APOPTOTIC SIGNALLING PATHWAYS Author keyword 1 50% 1% 1
5 CHUQ MOL ENDOCRINOL Address 1 50% 1% 1
6 EXPTL PHYSIOL Address 1 50% 1% 1
7 JINAN CITY CENT HOSP Address 1 50% 1% 1
8 OSTEOBLASTIC CELL DIFFERENTIATION Author keyword 1 50% 1% 1
9 STAGE D3 Author keyword 1 50% 1% 1
10 TRAMP C1 CELLS Author keyword 1 50% 1% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 OSTEOBLASTIC METASTASIS 4 36% 7% 8 Search OSTEOBLASTIC+METASTASIS Search OSTEOBLASTIC+METASTASIS
2 3 D COLLAGEN 1 50% 1% 1 Search 3+D+COLLAGEN Search 3+D+COLLAGEN
3 AHTO 7 1 50% 1% 1 Search AHTO+7 Search AHTO+7
4 ANTI APOPTOTIC SIGNALLING PATHWAYS 1 50% 1% 1 Search ANTI+APOPTOTIC+SIGNALLING+PATHWAYS Search ANTI+APOPTOTIC+SIGNALLING+PATHWAYS
5 OSTEOBLASTIC CELL DIFFERENTIATION 1 50% 1% 1 Search OSTEOBLASTIC+CELL+DIFFERENTIATION Search OSTEOBLASTIC+CELL+DIFFERENTIATION
6 STAGE D3 1 50% 1% 1 Search STAGE+D3 Search STAGE+D3
7 TRAMP C1 CELLS 1 50% 1% 1 Search TRAMP+C1+CELLS Search TRAMP+C1+CELLS
8 OSTEOBLASTIC METASTASES 0 14% 3% 3 Search OSTEOBLASTIC+METASTASES Search OSTEOBLASTIC+METASTASES
9 OSTEOPLASIA 0 33% 1% 1 Search OSTEOPLASIA Search OSTEOPLASIA
10 PA III CELLS 0 33% 1% 1 Search PA+III+CELLS Search PA+III+CELLS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DISEASE AGGRESSIVITY 15 88% 6% 7
2 OSTEOBLASTIC METASTASES 6 31% 13% 16
3 COLLAGEN GEL SYSTEM 5 50% 6% 7
4 DISEASE AGGRESSIVENESS 3 100% 3% 3
5 TUMOR CELL INTERACTIONS 1 50% 2% 2
6 TERM TISSUE CULTURES 1 40% 2% 2
7 LINE PC 3 1 13% 5% 6
8 ANDROGEN ABLATION THERAPY 1 15% 4% 5
9 SCLEROTIC BONE METASTASES 1 50% 1% 1
10 5 3 3 DIMETHYL 1 TRIAZENOIMIDAZOLE 4 CARBOXAMIDE NSC 45388 1 22% 2% 2

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
CHEMOTHERAPY-INDUCED HYPOCALCEMIA 2010 0 13 62%
Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer 2013 2 129 19%
Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications 2013 0 56 43%
Combination of dexamethasone and a somatostatin analogue in the treatment of advanced prostate cancer 2002 12 68 26%
Insulin-like growth factor I and urokinase-type plasminogen activator bioregulation system as a survival mechanism of prostate cancer cells in osteoblastic metastases: Development of anti-survival factor therapy for hormone-refractory prostate cancer 2000 33 128 19%
Molecular evidence-based use of bone resorption-targeted therapy in prostate cancer patients at high risk for bone involvement 2002 7 63 21%
SKELETAL METASTASES IN ADVANCED PROSTATE-CANCER - CELL BIOLOGY AND THERAPY 1995 39 87 20%
The molecular concept of prostate cancer 1996 7 27 22%
Molecular biology and cellular physiology of refractoriness to androgen ablation therapy in advanced prostate cancer 2001 33 188 12%
HYPOCALCEMIA IN CANCER 1990 12 25 20%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CHUQ MOL ENDOCRINOL 1 50% 0.8% 1
2 EXPTL PHYSIOL 1 50% 0.8% 1
3 JINAN CITY CENT HOSP 1 50% 0.8% 1
4 ANNA SEILER HAUS INSELSPITAL 0 33% 0.8% 1
5 MED RADIOTHER Y 0 33% 0.8% 1
6 ENDO ONCO S 0 17% 0.8% 1
7 NINEWELLS HOSP MED BIOCHEM MED 0 17% 0.8% 1
8 ONCOL STUDIES 0 17% 0.8% 1
9 BRIGHT SPARKS UNIT 0 13% 0.8% 1
10 BIOL NANOSCI ADV MED 0 100% 0.8% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000216332 ZOLEDRONIC ACID//SKELETAL RELATED EVENTS//BONE METASTASES
2 0.0000155109 UNIT IMMUNOMICROBIO ENVIRONM CARCINOGENESIS//ANTI INTERLEUKIN 6 ANTIBODY//AUTOCRINE AND PARACRINE LOOPS
3 0.0000103470 HIGH DOSE METHYLPREDNISOLONE//GRP MOL ONCOSURG//AMINOSTEROID
4 0.0000102343 POSTGASTRECTOMY BONE DISEASE//FUNDECTOMY//GASTROCALCIN
5 0.0000099246 AZALINE B//ANTIOVULATORY ACTIVITY//LHRH ANTAGONISTS
6 0.0000091329 SHIONOGI CARCINOMA 115//VITAMIN B 12B//CLIN EXPT PATHOPHYSIOL
7 0.0000088946 IONIZED CALCIUM//ELECTROLYTE BALANCED HEPARIN//CORRECTION FORMULAE
8 0.0000087428 ENDOCRINE POLYPEPTIDE CANC//GHRH ANTAGONISTS//GHRH ANTAGONIST
9 0.0000083839 MARROW FIBROBLASTS//OSTEOPROGENITORS//OSTEOBLASTIC MARKERS
10 0.0000082338 PROSTATE DEVELOPMENT//BIOL SCI VET MED//PROSTATE STEM CELL